MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • All Meetings
    • 2026 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • 2017 International Congress

    “Essential tremor” as a presenting symptom of neuronal intranuclear inclusion disease (NIID).

    Z. Xu, W.-Y. Yu, J. Tan, H.-Y. Lee, Q. Cheng, T. Lim (Singapore, Singapore)

    Objective: To describe a patient with late onset, sporadic NIID who had a tremor as his first complaint. Background: NIID is a rare, slowly progressive…
  • 2017 International Congress

    Diagnostic utility of regional [18F]AV-1451 tau-PET measurements in PSP

    J. Whitwell, V. Lowe, N. Tosakulwong, S. Weigand, M. Senjem, C. Schwarz, A. Spychalla, R. Petersen, C. Jack, K. Josephs (Rochester, MN, USA)

    Objective: To determine the diagnostic utility of regional subcortical [18F]AV-1451 tau-PET measurements to differentiate progressive supranuclear palsy (PSP) from age-matched controls and Alzheimer’s dementia patients.…
  • 2017 International Congress

    Application of a Qualitative Model to Elucidate the Role of the Alpha-Synuclein System in Parkinson’s Disease.

    C. Friedrich, W. Zago, S. Gardai, G. Tonn, M. Reed (Cupertino, CA, USA)

    Objective: Objective: In order to improve the understanding of the alpha-synuclein system and its role in Parkinson’s disease, Elan and Rosa collaborated in the development…
  • 2017 International Congress

    Extended “Timed Up and Go”: A Clinical Indicator of Cognitive State in Parkinson’s Disease?

    T. Evans, A. Jefferson, M. Byrnes, S. Walters, S. Ghosh, F. Mastaglia, B. Power, R. Anderton (Perth, Australia)

    Objective: To evaluate an extended Timed Up and Go (extended-TUG) as a potential holistic indicator of Parkinson’s disease; hypothesised to correlate closely with disease severity…
  • 2017 International Congress

    APOE4+ status increases rate of longitudinal cognitive decline in Parkinson Disease patients with low CSF Aβ42

    K. Leaver, T. Hendershott, D. Zhu, L. Tian, K. Poston (Stanford, CA, USA)

    Objective: To determine if the presence of APOEɛ4 allele (APOE4+) predicts longitudinal cognitive decline in Parkinson’s disease (PD) patients with low CSFAβ42 Background: Cognitive impairment…
  • 2017 International Congress

    Anosognosia for Levododopa-induced Dyskinesias in PD – Frequency

    R. Doyle Maia, F. Cardoso, P. Caramelli (Vitória, Brazil)

    Objective: To evaluate the factors and possible mechanisms associated with anosognosia for LIDs in patients with PD using movie presentations and mirrored self-images. Background: Levodopa-induced…
  • 2017 International Congress

    Apomorphine infusion does not impair cognitive action control in Parkinson’s disease

    J. Duprez, J.-F. Houvenaghel, S. Drapier, D. Drapier, M. Vérin, P. Sauleau (Rennes, France)

    Objective: We sought to verify that apomorphine infusion did not alter cognitive action control.We sought to verify that apomorphine infusion did not alter cognitive action…
  • 2017 International Congress

    Compulsive sexual behaviour in Parkinson’s disease is associated with higher doses of levodopa

    P. Barbosa, T. Warner, A. Djamshidian (London, United Kingdom)

    Objective: To assess whether compulsive sexual behaviour in individuals with PD is associated with higher doses of levodopa.  Background: The lifetime prevalence of compulsive sexual behaviour…
  • 2017 International Congress

    Tremor as the first symptom reported by Parkinson’s disease patients is a predictor of future motor subtype and levodopa-induced dyskinesia.

    A. Schumacher-Schuh, F. Drumond, J. Leal, M. Dotto, S. Machado, C. Rieder (Porto Alegre, Brazil)

    Objective: To better delineate risk profiles for the development of levodopa-induced dyskinesia is an important effort that can help understand this phenomenon and could impact…
  • 2017 International Congress

    Movement Disorders in Demyelinating Diseases: a retrospective review from a tertiary academic center.

    G. Suarez-Cedeno, M. Raja (Houston, TX, USA)

    Objective: To review the prevalence of movement disorders (MD) in patients with demyelinating diseases (DD) treated at a tertiary academic center and to characterize their therapeutic response…
  • « Previous Page
  • 1
  • …
  • 1580
  • 1581
  • 1582
  • 1583
  • 1584
  • …
  • 1942
  • Next Page »

Related Sites

International Parkinson and Movement Disorder Society

The Society that manages the annual International Congress »

International Congress

The official website for the International Congress of Parkinson’s and Movement Disorders® »

  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley